Is HLH an autoimmune disease

Janka, G. E. (2007). Familial and acquired hemophagocytic lymphohistiocytosis. European journal of pediatrics, 166(2), 95-109.

Henter, J. I., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., ... & Janka, G. (2007). HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric blood & cancer, 48(2), 124-131.

Henter, J. I., Elinder, G., & Ost, A. (1991, February). Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. In Seminars in oncology (Vol. 18, No. 1, pp. 29-33).

Henter, J. I., Samuelsson-Horne, A., Arico, M., Egeler, R. M., Elinder, G., Filipovich, A. H., ... & Janka, G. (2002). Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood, 100(7), 2367-2373.

Filipovich, A. H. (2009). Hemophagocytic lymphohistiocytosis (HLH) and related disorders. ASH Education Program Book, 2009(1), 127-131.

Jordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004). An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood, 104(3), 735-743.

Imashuku, S., Kuriyama, K., Teramura, T., Ishii, E., Kinugawa, N., Kato, M., ... & Hibi, S. (2001). Requirement for etoposide in the treatment of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis. Journal of Clinical Oncology, 19(10), 2665-2673.

zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., ... & Maul-Pavicic, A. (2009). Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. The American Journal of Human Genetics85(4), 482-492.